Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis

Structure of prolyl-tRNA synthetase-halofuginone complex provides basis for development of drugs against malaria and toxoplasmosis

The Chinese herb Dichroa febrifuga has traditionally treated malaria-associated fever. Its active component febrifugine (FF) and derivatives such as halofuginone (HF) are potent anti-malarials. Here, we show that FF-based derivatives arrest parasite growth by direct interaction with and inhibition o...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Jain, V, Yogavel, M, Oshima, Y, Kikuchi, H, Touquet, B, Hakimi, M, Sharma, A
Formáid:	Journal article
Foilsithe / Cruthaithe:	Cell Press 2015

Míreanna comhchosúla

Targeting prolyl-tRNA synthetase to accelerate drug discovery against malaria, leishmaniasis, toxoplasmosis, cryptosporidiosis, and coccidiosis.
de réir: Jain, V, et al.
Foilsithe / Cruthaithe: (2017)

Elucidating the path to Plasmodium prolyl-tRNA synthetase inhibitors that overcome halofuginone resistance
de réir: Mark A. Tye, et al.
Foilsithe / Cruthaithe: (2022-08-01)

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis
de réir: Manickam Yogavel, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Targeting prolyl-tRNA synthetase via a series of ATP-mimetics to accelerate drug discovery against toxoplasmosis.
de réir: Manickam Yogavel, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Double drugging of prolyl-tRNA synthetase provides a new paradigm for anti-infective drug development.
de réir: Yogavel Manickam, et al.
Foilsithe / Cruthaithe: (2022-03-01)

ATP mimetics targeting prolyl-tRNA synthetases as a new avenue for antimalarial drug development
de réir: Siddhartha Mishra, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Structural basis of malaria parasite phenylalanine tRNA-synthetase inhibition by bicyclic azetidines
de réir: Manmohan Sharma, et al.
Foilsithe / Cruthaithe: (2021-01-01)

Dimerization of arginyl-tRNA synthetase by free heme drives its inactivation in plasmodium falciparum
de réir: Jain, V, et al.
Foilsithe / Cruthaithe: (2016)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
de réir: Kurata, K, et al.
Foilsithe / Cruthaithe: (2023)

The cytoplasmic prolyl-tRNA synthetase of the malaria parasite is a dual-stage target of febrifugine and its analogs
de réir: Pepper, L. R., et al.
Foilsithe / Cruthaithe: (2016)

Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
de réir: Keiji Kurata, et al.
Foilsithe / Cruthaithe: (2023-01-01)

Correction: Prolyl-tRNA synthetase as a novel therapeutic target in multiple myeloma
de réir: Keiji Kurata, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Control of fibrosis with enhanced safety via asymmetric inhibition of prolyl‐tRNA synthetase 1
de réir: Ina Yoon, et al.
Foilsithe / Cruthaithe: (2023-05-01)

Phosphocode-dependent glutamyl-prolyl-tRNA synthetase 1 signaling in immunity, metabolism, and disease
de réir: Eun-Young Lee, et al.
Foilsithe / Cruthaithe: (2023-10-01)

DWN12088, A Prolyl-tRNA Synthetase Inhibitor, Alleviates Hepatic Injury in Nonalcoholic Steatohepatitis
de réir: Dong-Keon Lee, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Glutamyl-prolyl-tRNA synthetase 1 coordinates early endosomal anti-inflammatory AKT signaling
de réir: Eun-Young Lee, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Pyrrolysyl-tRNA Synthetase, an Aminoacyl-tRNA Synthetase for Genetic Code Expansion
de réir: Ana Crnković, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Protein Translation Enzyme lysyl-tRNA Synthetase Presents a New Target for Drug Development against Causative Agents of Loiasis and Schistosomiasis.
de réir: Arvind Sharma, et al.
Foilsithe / Cruthaithe: (2016-11-01)

Cardiomyocyte-Specific Loss of Glutamyl-prolyl-tRNA Synthetase Leads to Disturbed Protein Homeostasis and Dilated Cardiomyopathy
de réir: Jiangbin Wu, et al.
Foilsithe / Cruthaithe: (2023-12-01)

Origin and evolution of glutamyl-prolyl tRNA synthetase WHEP domains reveal evolutionary relationships within Holozoa.
de réir: Partho Sarothi Ray, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Discovery and pharmacological characterization of a new class of prolyl-tRNA synthetase inhibitor for anti-fibrosis therapy.
de réir: Akira Shibata, et al.
Foilsithe / Cruthaithe: (2017-01-01)

Drug targeting of one or more aminoacyl-tRNA synthetase in the malaria parasite Plasmodium falciparum
de réir: Manickam, Y, et al.
Foilsithe / Cruthaithe: (2018)

Aminoacyl-tRNA synthetases of the multi-tRNA synthetase complex and their role in tumorigenesis
de réir: Krishnendu Khan, et al.
Foilsithe / Cruthaithe: (2022-05-01)

No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
de réir: Wonsuk Shin, et al.
Foilsithe / Cruthaithe: (2024-01-01)

Adenosine-Mimicking Derivatives of 3-Aminopyrazine-2-Carboxamide: Towards Inhibitors of Prolyl-tRNA Synthetase with Antimycobacterial Activity
de réir: Vinod Sukanth Kumar Pallabothula, et al.
Foilsithe / Cruthaithe: (2022-10-01)

Safety, tolerability, pharmacokinetic/pharmacodynamic characteristics of bersiporocin, a novel prolyl‐tRNA synthetase inhibitor, in healthy subjects
de réir: Min Young Park, et al.
Foilsithe / Cruthaithe: (2023-07-01)

A genomic glimpse of aminoacyl-tRNA synthetases in malaria parasite <it>Plasmodium falciparum</it>
de réir: Santoni Daniele, et al.
Foilsithe / Cruthaithe: (2009-12-01)

Chimeric design of pyrrolysyl-tRNA synthetase/tRNA pairs and canonical synthetase/tRNA pairs for genetic code expansion
de réir: Wenlong Ding, et al.
Foilsithe / Cruthaithe: (2020-06-01)

Analogs of natural aminoacyl-tRNA synthetase inhibitors clear malaria in vivo
de réir: Camacho, Noelia, et al.
Foilsithe / Cruthaithe: (2015)

Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase Inhibitors
de réir: Okaniwa, Masanori, et al.
Foilsithe / Cruthaithe: (2021)

Aminoacyl-tRNA Synthetases: On Anti-Synthetase Syndrome and Beyond
de réir: Angeles S. Galindo-Feria, et al.
Foilsithe / Cruthaithe: (2022-05-01)

Glutamyl-Prolyl-tRNA Synthetase Regulates Epithelial Expression of Mesenchymal Markers and Extracellular Matrix Proteins: Implications for Idiopathic Pulmonary Fibrosis
de réir: Dae-Geun Song, et al.
Foilsithe / Cruthaithe: (2018-11-01)

Drug targeting of aminoacyl-tRNA synthetases in Anopheles species and Aedes aegypti that cause malaria and dengue
de réir: Soumyananda Chakraborti, et al.
Foilsithe / Cruthaithe: (2021-12-01)

Peptidyl tRNA Hydrolase Is Required for Robust Prolyl-tRNA Turnover in Mycobacterium tuberculosis
de réir: Francesca G. Tomasi, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Aminoacyl‐tRNA synthetases in medicine and disease
de réir: Peng Yao, et al.
Foilsithe / Cruthaithe: (2013-02-01)

Seryl-tRNA Synthetases in Translation and Beyond
de réir: Marko Močibob, et al.
Foilsithe / Cruthaithe: (2016-06-01)

Evolution of Life on Earth: tRNA, Aminoacyl-tRNA Synthetases and the Genetic Code
de réir: Lei Lei, et al.
Foilsithe / Cruthaithe: (2020-03-01)

The Mitochondrial Aminoacyl tRNA Synthetases: Genes and Syndromes
de réir: Daria Diodato, et al.
Foilsithe / Cruthaithe: (2014-01-01)

Editorial: Noncanonical functions of Aminoacyl-tRNA synthetases
de réir: Litao Sun, et al.
Foilsithe / Cruthaithe: (2023-02-01)

Aminoacyl-tRNA synthetases in human health and disease
de réir: Alexandra K. Turvey, et al.
Foilsithe / Cruthaithe: (2022-10-01)